PC
AGN

Paulson & Co’s Allergan plc AGN Stock Holding History

Paulson & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-602,130
Closed -$107M – 36
2020
Q1 		$107M Sell
602,130
-2,060,353
-77% -$388M 4.07% 10
2019
Q4 		$509M Sell
2,662,483
-269,687
-9% -$48.7M 10.99% 3
2019
Q3 		$493M Buy
2,932,170
+682,670
+30% +$111M 9.88% 2
2019
Q2 		$377M Buy
2,249,500
+700,000
+45% +$96.9M 6.4% 3
2019
Q1 		$227M Hold
1,549,500
– – 4.76% 8
2018
Q4 		$207M Sell
1,549,500
-72,000
-4% -$11.8M 4.96% 6
2018
Q3 		$309M Sell
1,621,500
-277,224
-15% -$50.9M 5.78% 6
2018
Q2 		$317M Hold
1,898,724
– – 6.47% 5
2018
Q1 		$320M Hold
1,898,724
– – 6.99% 5
2017
Q4 		$311M Sell
1,898,724
-281,568
-13% -$50.5M 6.06% 5
2017
Q3 		$447M Sell
2,180,292
-523,278
-19% -$122M 8.02% 4
2017
Q2 		$657M Sell
2,703,570
-238,264
-8% -$56M 8.89% 1
2017
Q1 		$703M Sell
2,941,834
-612,900
-17% -$143M 9.33% 1
2016
Q4 		$747M Sell
3,554,734
-336,400
-9% -$69.7M 9.41% 2
2016
Q3 		$896M Sell
3,891,134
-57,317
-1% -$14M 9.71% 2
2016
Q2 		$912M Sell
3,948,451
-1,469,849
-27% -$339M 9.28% 3
2016
Q1 		$1.45B Sell
5,418,300
-114,300
-2% -$32.7M 10.74% 1
2015
Q4 		$1.73B Sell
5,532,600
-1,649,400
-23% -$491M 10.34% 1
2015
Q3 		$1.95B Buy
7,182,000
+7,800
+0.1% +$2.4M 10.13% 1
2015
Q2 		$2.18B Buy
7,174,200
+1,533,412
+27% +$457M 10.04% 1
2015
Q1 		$1.68B Buy
5,640,788
+4,080,187
+261% +$1.16B 8.55% 2
2014
Q4 		$402M Buy
1,560,601
+498,401
+47% +$125M 2.07% 18
2014
Q3 		$256M Buy
1,062,200
+762,200
+254% +$171M 1.06% 32
2014
Q2 		$66.9M Hold
300,000
– – 0.29% 54
2014
Q1 		$61.8M Buy
+300,000
New +$59.4M 0.3% 57

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Paulson & Co's AGN Position: Q2 2020 in Review

Paulson & Co sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 602,130 shares — an estimated $107M sold.

Paulson & Co first reported a position in AGN in Q1 2014 and held it in 25 quarters. The position peaked at $2.18B in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Paulson & Co reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Paulson & Co sold 602,130 Allergan plc shares in Q2 2020, an estimated $107M.
  • Paulson & Co first reported a position in Allergan plc in Q1 2014 and held it in 25 quarters.
  • Paulson & Co's Allergan plc position peaked at $2.18B in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Paulson & Co's 13F filing for Q2 2020, filed 14 Aug 2020.